ArticleJAMA2024

Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials.

JoAnn V Pinkerton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.